The Defense Threat Reduction Agency (DTRA) Small Business Innovation Research (SBIR) program funds innovative small businesses developing technologies to counter chemical, biological, radiological, nuclear, and high-explosive (CBRNE) threats. DTRA’s mission is uniquely focused on deterrence, detection, attribution, response, and consequence management for some of the most complex and high-impact national security risks facing the United States and its allies.

Unlike many DoD SBIR components that emphasize platform modernization or near-term acquisition, DTRA SBIR prioritizes threat reduction, resilience, and preparedness across both military and civilian domains. Topics are tightly aligned with real-world operational needs, including counter-WMD missions, force protection, global biosurveillance, treaty verification, nuclear detection, forensic attribution, and emergency response in contested or austere environments.

Technology Priority Areas

DTRA SBIR topics frequently span:

• Chemical and biological threat detection and diagnostics

• Radiological and nuclear sensing, modeling, and attribution

• Biosurveillance, early warning, and outbreak analytics

• Threat modeling, risk assessment, and consequence simulation

• Decontamination technologies and materials

• Medical countermeasures and exposure mitigation

• Autonomous sensing, AI/ML analytics, and data fusion

• Decision-support tools for CBRNE response and recovery

Many topics emphasize field deployability, low-power operation, ruggedization, rapid response, and integration with military, intelligence, or interagency workflows.

SBIR Phases and Funding

• Phase I awards typically range from $150,000–$250,000, supporting feasibility studies, proof-of-concept development, modeling, early prototyping, or laboratory validation.

• Phase II awards commonly range from $1,000,000–$1,700,000, supporting prototype maturation, system integration, field testing, advanced modeling, or operational demonstration.

• Direct-to-Phase-II pathways may be available for companies with validated prototypes or prior R&D results.

Transition potential is a major evaluation criterion. Successful projects often move toward operational pilots, OTA follow-on efforts, government test ranges, interagency adoption, or dual-use commercialization in public health, emergency management, energy, environmental monitoring, or critical infrastructure protection.

Eligibility and Teaming

Eligibility follows standard SBIR rules:

• U.S.-owned, for-profit small businesses under 500 employees

• Principal Investigator primarily employed by the small business

• At least 50% of R&D performed by the small business

Universities, national laboratories, federally funded R&D centers (FFRDCs), hospitals, and specialized testing facilities frequently participate as subcontractors—especially for high-containment labs, advanced modeling, animal studies, or field-testing infrastructure. Projects involving hazardous materials must comply with applicable biosafety, security, and regulatory requirements.

Why DTRA SBIR Is Distinct

DTRA SBIR is especially valuable for companies developing high-impact technologies that sit at the intersection of defense, public health, science, and emergency response. The program supports work that may not fit cleanly into traditional acquisition pathways but is essential for national preparedness, deterrence, and resilience against low-probability, high-consequence threats.

ScienceDocs Can Help

ScienceDocs has extensive experience supporting DTRA SBIR and threat-reduction proposals, including biosurveillance systems, CBRNE detection technologies, modeling and simulation platforms, medical countermeasures, and AI-enabled analytics. We assist with technical narrative development, feasibility framing, transition strategy, regulatory considerations, and full proposal production.

To request expert support for a DTRA SBIR submission, please visit:
https://www.sciencedocs.com/quotes